Literature DB >> 21204735

Tits and bits of HIV Tat protein.

Manish K Johri1, Ritu Mishra, Chintan Chhatbar, Salini K Unni, Sunit K Singh.   

Abstract

INTRODUCTION: HIV-Tat protein displays an array of functions that are essential for HIV replication. The structural flexibility of Tat protein has been regarded as one of the unique features responsible for sustaining diverse functions, from facilitated membrane-crossing ability to strong affinity for RNA binding. AREAS COVERED: RNA binding ability and presence of multiple interacting domains in the same protein are very important properties of HIV-Tat protein. Tat protein has shown great ability to influence cellular and viral gene expression. We discuss the functions of HIV Tat protein, describing its structural significance, secretion and uptake of HIV Tat protein by immune cells, post-translational modifications and role of HIV Tat protein in HIV pathogenesis. EXPERT OPINION: Perturbation in expression of many cytokines and chemokines by HIV-Tat protein exhibits downstream immune suppressive function as well as activation of several apoptotic genes. This explains the massive death of immune cells due to bystander effect of HIV Tat protein among HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21204735     DOI: 10.1517/14712598.2011.546339

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  20 in total

1.  Fluorescently-labeled RNA packaging into HIV-1 particles: Direct examination of infectivity across central nervous system cell types.

Authors:  Ruqiang Xu; Nazira El-Hage; Seth M Dever
Journal:  J Virol Methods       Date:  2015-08-10       Impact factor: 2.014

2.  The 5' UTR of HIV-1 full-length mRNA and the Tat viral protein modulate the programmed -1 ribosomal frameshift that generates HIV-1 enzymes.

Authors:  Johanie Charbonneau; Karine Gendron; Gerardo Ferbeyre; Léa Brakier-Gingras
Journal:  RNA       Date:  2012-01-27       Impact factor: 4.942

3.  Autophagy restricts HIV-1 infection by selectively degrading Tat in CD4+ T lymphocytes.

Authors:  Sophie Sagnier; Coralie F Daussy; Sophie Borel; Véronique Robert-Hebmann; Mathias Faure; Fabien P Blanchet; Bruno Beaumelle; Martine Biard-Piechaczyk; Lucile Espert
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

Review 4.  Historical review of the causes of cancer.

Authors:  Clarke Brian Blackadar
Journal:  World J Clin Oncol       Date:  2016-02-10

Review 5.  Targeting HIV transcription: the quest for a functional cure.

Authors:  Guillaume Mousseau; Sonia Mediouni; Susana T Valente
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

6.  A Bivalent Ligand Targeting the Putative Mu Opioid Receptor and Chemokine Receptor CCR5 Heterodimers: Binding Affinity versus Functional Activities.

Authors:  Yunyun Yuan; Christopher K Arnatt; Nazira El-Hage; Seth M Dever; Joanna C Jacob; Dana E Selley; Kurt F Hauser; Yan Zhang
Journal:  Medchemcomm       Date:  2013-05-01       Impact factor: 3.597

7.  HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase.

Authors:  Ferdous Kadri; Marco Pacifici; Anna Wilk; Amanda Parker-Struckhoff; Luis Del Valle; Kurt F Hauser; Pamela E Knapp; Christopher Parsons; Duane Jeansonne; Adam Lassak; Francesca Peruzzi
Journal:  J Biol Chem       Date:  2015-11-03       Impact factor: 5.157

8.  HIV-1 Tat protein induces PD-L1 (B7-H1) expression on dendritic cells through tumor necrosis factor alpha- and toll-like receptor 4-mediated mechanisms.

Authors:  Rémi Planès; Lbachir BenMohamed; Kaoutar Leghmari; Pierre Delobel; Jacques Izopet; Elmostafa Bahraoui
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

9.  Overexpression of PRMT6 does not suppress HIV-1 Tat transactivation in cells naturally lacking PRMT6.

Authors:  Haran Sivakumaran; Min-Hsuan Lin; Ann Apolloni; Vincent Cutillas; Hongping Jin; Dongsheng Li; Ting Wei; David Harrich
Journal:  Virol J       Date:  2013-06-24       Impact factor: 4.099

10.  Xentry, a new class of cell-penetrating peptide uniquely equipped for delivery of drugs.

Authors:  Kristopher Montrose; Yi Yang; Xueying Sun; Siouxsie Wiles; Geoffrey W Krissansen
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.